Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kelch-like protein 10 is a member of the BTB-Kelch superfamily containing an N-terminal BTB/POZ domain, a BACK domain, and six C-terminal Kelch repeats[3][7][8]. It is primarily expressed in testicular tissue and functions as an adaptor protein within a CUL3-dependent E3 ubiquitin ligase complex during spermatogenesis, targeting specific proteins for ubiquitination and proteasomal degradation[2][3][8]. Mutations in the KLHL10 gene are associated with oligozoospermia and male infertility[3][7]. There is currently no evidence that it functions as a therapeutic target (such as a receptor, enzyme, transporter, or transcription factor), nor are there any drugs targeting or modulating KLHL10 in clinical use[2][3][8]. The gene encoding this protein is located on human chromosome 17[7]. Kelch-like protein 10's closest paralog is KLHL2[3]. While the broader KLHL protein family is involved in ubiquitin-mediated protein degradation and associated with human diseases (including cancers and some Mendelian diseases)[1], KLHL10's primary clinical relevance is in reproductive health. Standardized identifiers include HGNC:18829, NCBI Gene:317719, and UniProtKB:Q6JEL2[3][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch-like protein 10 (KLHL10).